New insights into stem cell behavior under low-oxygen conditions support innovative therapies for tendon repair

Recently published research in Stem Cells International, conducted by Prof. Nick Forsyth, an expert in molecular and stem cell biology, sheds new light on the role of low-oxygen environments in tendon repair. The study demonstrates that tendon-specific stem cells (TSCs) efficiently differentiate into tenocytes under low-oxygen conditions—without the need for external growth factors. This breakthrough highlights the importance of a physiologically relevant oxygen environment for improving regenerative therapies for tendon injuries.

The research was conducted using SCI-tive™ hypoxia workstations from Baker Ruskinn, which provide a stable, closed cell culture environment with precise control over oxygen levels. By minimizing fluctuations in temperature, humidity, and oxidation, these workstations create ideal conditions for culturing and studying sensitive cell types such as stem cells. The spacious interior accommodates all stages of the cell culture process and eliminates the need for an open workstation. Optional HEPA filtration and an advanced safety system also ensure optimal protection for both users and cell cultures.

In response to the growing need for advanced cell culture environments, The Baker Company offers the InvivO₂™ Hypoxia Workstation—an innovative platform that allows researchers to accurately simulate low-oxygen conditions. This is essential for unraveling stem cell mechanisms and developing effective, customized treatments for tendon injuries.

“With the InvivO₂, researchers can precisely replicate physiological oxygen levels. This is crucial for a better understanding of stem cell behavior and for optimizing cell therapies,” said Diko Strietman, Managing Director Baker Europe.

By integrating this technology into laboratories worldwide, the development of personalized and less invasive treatment methods is accelerated. This not only contributes to better patient outcomes but also helps reduce the burden on healthcare systems.